French Maritime Pine Bark for Skin Health
The skin research on French maritime pine bark extract is smaller than the vein research but genuinely interesting, because a few studies went beyond “people felt their skin looked better” and measured biology. In one 12-week trial, the oral extract improved skin elasticity and hydration and, in skin biopsies, coincided with more gene expression of collagen type I and hyaluronic-acid synthase — the machinery skin uses to stay firm and moist. Other work suggests oral doses raise the amount of ultraviolet (UV) needed to redden skin (a photoprotection signal) and that the extract can lighten melasma, the stubborn facial pigmentation that often follows sun and hormones. This page separates the measured findings from the marketing, and notes that most trials are small.
Table of Contents
- How Skin Ages and Where Antioxidants Fit
- Elasticity, Hydration, and the Collagen Study
- Ultraviolet, Photoaging, and Oral Photoprotection
- Melasma and Pigmentation
- The Skin Mechanism in Detail
- Wound Healing
- Oral Versus Topical
- Doses and Durations Used in Skin Trials
- Cautions and the Evidence Caveat
- Hair Density in Menopausal Women
- Key Research Papers
- External Resources
- Connections
- Featured Videos
How Skin Ages and Where Antioxidants Fit
Skin ages in two overlapping ways. Intrinsic aging is the slow, genetically programmed loss of collagen and elastin over the decades. Photoaging is the faster damage caused by ultraviolet light, which generates free radicals, triggers inflammation, and switches on enzymes called matrix metalloproteinases (MMPs) that chew up collagen. The visible results — wrinkles, sagging, dryness, and uneven brown pigmentation — are largely the sum of lost structural proteins, reduced water-holding molecules, and disordered pigment.
This is exactly the kind of problem where an antioxidant that also calms inflammation could, in principle, help: by mopping up ultraviolet-generated free radicals, dialing down the inflammatory signals that activate collagen-destroying enzymes, and supporting the cells that build collagen and hyaluronic acid. Pine bark extract's procyanidins do all three in the laboratory, which is why it has been tested on skin. The question, as always, is whether laboratory activity translates into a visible, reliable human effect.
Elasticity, Hydration, and the Collagen Study
The most cited skin study is Marini and colleagues (2012). In a 12-week study of 20 healthy postmenopausal women, daily oral pine bark extract significantly improved measured skin elasticity and hydration compared with baseline (each woman's skin was measured before, during and after supplementation; the abstract describes no placebo group) — and, importantly, the researchers took skin biopsies and found a significant increase in the expression of the gene for hyaluronic acid synthase-1, the enzyme that makes hyaluronic acid (skin's main water-holding molecule), along with what they described as “a noticeable increase in gene expression involved in collagen de novo synthesis”; the paper's title names this as collagen type I. The effect on hydration was most pronounced in women whose skin was drier to begin with.
What makes this study stand out is that it did not stop at a subjective “my skin looks better” questionnaire. It connected an outward change (softer, more elastic, better-hydrated skin) to an inward, molecular change (more of the actual genes that build collagen and hold water). That is a stronger kind of evidence than a satisfaction survey. Di Cerbo and colleagues (2015) later reported that a dietary supplement containing the pine bark extract improved facial photoaging measures including hydration and skin tone, along with shifts in serum markers — though because that product contained more than one ingredient, the effect cannot be attributed to the pine bark extract alone.
A placebo-controlled trial followed in 2021. In a double-blind, randomized, crossover study of 76 people working outdoors in Beijing, China, from spring to autumn, the oral extract (2 × 50 mg a day for a total of 12 weeks) prevented a decrease in skin hydration, transepidermal water loss (water loss through the skin) and skin darkening during the dry autumn season, even though the participants were constantly exposed to raised levels of fine-particle air pollution (PM2.5) and seasonal changes in humidity and temperature. It also improved skin elasticity irrespective of the season. These effects were not seen when the same people took placebo.
Ultraviolet, Photoaging, and Oral Photoprotection
“Oral photoprotection” is the idea that an ingested antioxidant can make skin more resistant to ultraviolet damage from the inside — not as a replacement for sunscreen, but as a supplement to it. Saliou and colleagues (2001) provided the key mechanistic human evidence: oral supplementation raised the minimal erythema dose — the amount of ultraviolet needed to visibly redden the skin — and, in keratinocyte experiments, the extract blunted ultraviolet-driven gene activity controlled by the inflammatory transcription factor NF-κB.
In that study, 21 volunteers took 1.10 mg per kg body weight a day for the first 4 weeks and 1.66 mg/kg a day for the next 4 weeks, and their minimal erythema dose was compared with their own measurements before supplementation; the ultraviolet dose needed to redden the skin rose significantly during supplementation. The NF-κB result came from a human keratinocyte cell line (HaCaT) grown in the laboratory, not from the volunteers.
Practically, this means the extract appears to modestly increase the skin's threshold for sunburn-type redness and to dampen the inflammatory cascade ultraviolet sets off. That is a real and plausible effect, but it is a modest one. It does not approach the protection of a broad-spectrum SPF sunscreen, and nothing in these studies supports longer sun exposure after taking a supplement. On the evidence, the oral extract is at most a small internal add-on to sun-smart habits, not a substitute for them.
Melasma and Pigmentation
Melasma is a common, frustrating condition in which brown or gray-brown patches appear on the face, usually driven by a combination of sun exposure and hormones (pregnancy, oral contraceptives). It is notoriously hard to treat and prone to relapse.
Two studies are relevant. Ni and colleagues (2002) ran an open (uncontrolled) trial in 30 women with melasma using the oral extract for 30 days (one 25 mg tablet three times daily, 75 mg a day) and reported a reduction in the size and intensity of the pigmented areas, with good tolerability: the average melasma area fell by 25.86 ± 20.39 mm² (p < 0.001). Because it lacked a placebo group, it can only be considered preliminary. The stronger study is Lima and colleagues (2021): a double-blind, randomized, placebo-controlled trial that added the oral standardized extract to standard triple-combination bleaching cream for facial melasma in women, and reported added benefit over the cream plus placebo. In its 44 women, 75 mg was taken orally twice a day for 60 days, and both groups also used a tinted sunscreen (SPF 50) by day and the triple-combination cream at bedtime; the melasma score (mMASI) fell by a mean 49% (95% CI 36–61%) with the extract and 34% (16–47%) with placebo, and there were no adverse effects related to the oral treatment. A properly controlled trial showing incremental benefit is meaningfully better evidence than an open study, and it makes melasma one of the more credible skin uses — as an adjunct to dermatologic treatment and diligent sun protection, not a stand-alone cure.
The Skin Mechanism in Detail
Pulling the threads together, the proposed skin mechanism has four parts, each supported by laboratory work such as Packer and colleagues' (1999) characterization of the extract's antioxidant biology:
- Free-radical scavenging. Procyanidins neutralize the reactive oxygen species ultraviolet generates, and help regenerate vitamins C and E in skin — reducing the oxidative damage that ages skin.
- Anti-inflammatory (NF-κB) action. By blunting NF-κB, the extract lowers the inflammatory signals that ultraviolet switches on — the same signals that drive redness and activate collagen-destroying enzymes.
- Protecting the collagen/elastin scaffold. OPCs bind to collagen and elastin and inhibit the MMP enzymes that break them down, helping preserve the structural proteins that keep skin firm.
- Supporting matrix synthesis. The Marini biopsy data suggest the extract is associated with more collagen I and hyaluronic-acid-synthase expression — i.e., building new scaffold and water-holding molecules, not only protecting the old.
Protecting existing structure while supporting new synthesis is a coherent, attractive dual action. It is well demonstrated in cells and small human studies; it has not been proven in large, long, independent trials.
Wound Healing
The same microcirculatory and anti-inflammatory mechanisms have been studied in wound healing. Toledo and colleagues (2017) randomized 30 adults with venous leg ulcers to the extract (50 mg orally, 3 times daily) or to diosmin/hesperidin (450/50 mg orally, twice daily), an oral treatment already used as add-on therapy for chronic venous insufficiency, for 90 days; both treatments had a similar effect on ulcer healing, and the authors concluded the extract has an add-on effect on venous ulcer healing similar to diosmin/hesperidin (covered in more depth on the Circulation & Veins page). Animal work, such as Dogan and colleagues (2017) in diabetic rats, suggests improved wound healing, but animal results do not automatically apply to people and are hypothesis-generating only.
The plausible link is blood supply: wounds heal on the strength of their microcirculation, and if the extract improves flow through small vessels and reduces inflammation, faster healing follows logically. This is promising but early; the human ulcer evidence concerns the extract as an adjunct to medical wound care — which diabetic and venous ulcers in particular depend on — not a replacement for it.
Oral Versus Topical
Most of the human skin evidence for pine bark extract is for the oral form — the elasticity/hydration, photoprotection, and melasma studies all used capsules or tablets. This is a little counterintuitive, since skincare is usually thought of as something applied to the skin. The logic is that an oral antioxidant reaches the skin through the bloodstream and acts systemically, including on the dermis and its blood supply, which a topical cream reaches less effectively.
Topical pine bark extract formulations exist and have been studied to a lesser degree, sometimes alongside oral use (as in some ulcer studies). For the measured benefits described here — firmness, hydration, pigmentation — the oral form is what the trials studied. Topical products may add localized benefit but rest on thinner evidence.
Doses and Durations Used in Skin Trials
The skin trials described on this page used these oral doses: 75 mg a day (one 25 mg tablet three times daily) for 30 days in the Ni melasma study; 75 mg twice a day for 60 days in the Lima melasma trial; 2 × 50 mg a day for 12 weeks in the Beijing outdoor-worker trial; 3 × 50 mg a day for 6 months in the hair-density trial; and 1.10 mg per kg body weight a day for 4 weeks followed by 1.66 mg/kg a day for 4 weeks in the Saliou ultraviolet study. The Marini elasticity study lasted 12 weeks. Changes in the trials were gradual, appearing over a couple of months rather than overnight, and the effect reported is subtle improvement — better hydration, a little more elasticity, some fading of pigmentation as an adjunct — rather than a dramatic transformation.
In the evidence, the extract plays a supporting role alongside the measures with stronger evidence for protecting skin — daily broad-spectrum sunscreen, not smoking, sleep, and (for pigmentation or aging concerns) proven dermatologic treatments such as retinoids. It has been studied as a complement to those, not a replacement for them.
Cautions and the Evidence Caveat
- Small studies. The skin literature is limited in size. The Marini and Lima studies are the more rigorous; the rest are preliminary. The 2020 Cochrane review of pine bark extract (27 randomized trials in 10 chronic disorders, none of them skin conditions) rated its evidence very low certainty and concluded that “no definitive conclusions regarding the efficacy or safety of pine bark extract supplements are possible.”
- Not a sunscreen. Any photoprotective effect measured is modest and internal; it is not comparable to SPF protection, and the studies give no basis for relaxing normal sun protection.
- Melasma relapses without sun protection. Melasma is driven by sun and hormones; without strict sun protection it relapses regardless of supplements. The controlled evidence covers the extract only as an adjunct to dermatologic care.
- Bleeding, blood pressure, surgery. The concerns raised for every use of the extract apply here too — people taking blood thinners or blood-pressure medication, and use around surgery — see Standardization & Safety.
- Pregnancy. Melasma often relates to pregnancy, and safety data for the extract in pregnancy are limited; decisions about supplements in pregnancy belong with a clinician.
Hair Density in Menopausal Women
A 2023 single-center, double-blind, randomized, placebo-controlled study gave the oral extract (3 × 50 mg a day for a total of 6 months) to menopausal women in Shanghai, China (76 women in all, extract and placebo groups together). Hair density, measured from digital photographs with image-analysis software, increased significantly by 30% after 2 months and 23% after 6 months on the extract; none of these effects were seen in the placebo group. The authors concluded that the extract “might have the potential to reduce hair loss in postmenopausal women.” This is a single trial.
Key Research Papers
- Marini A et al. (2012). Pycnogenol effects on skin elasticity and hydration coincide with increased gene expressions of collagen type I and hyaluronic acid synthase in women. Skin Pharmacology and Physiology — PubMed PMID: 22270036
- Saliou C et al. (2001). Solar ultraviolet-induced erythema in human skin and NF-κB-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radical Biology and Medicine — PubMed PMID: 11163532
- Ni Z, Mu Y, Gulati O (2002). Treatment of melasma with Pycnogenol. Phytotherapy Research — PubMed PMID: 12237816
- Lima PB et al. (2021). French maritime pine bark extract (Pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial. JEADV — PubMed PMID: 32841433
- Di Cerbo A et al. (2015). A dietary supplement improves facial photoaging and skin sebum, hydration and tonicity modulating serum fibronectin, neutrophil elastase 2, hyaluronic acid and carbonylated proteins. Journal of Photochemistry and Photobiology B — PubMed PMID: 25732262
- Packer L, Rimbach G, Virgili F (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radical Biology and Medicine — PubMed PMID: 10490291
- Rohdewald P (2002). A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. International Journal of Clinical Pharmacology and Therapeutics — PubMed PMID: 11996210
- Maimoona A et al. (2011). A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. Journal of Ethnopharmacology — PubMed PMID: 21044675
- Toledo RR et al. (2017). Effect of Pycnogenol on the healing of venous ulcers. Annals of Vascular Surgery — PubMed PMID: 27521821
- Dogan E et al. (2017). The effect of Pycnogenol on wound healing in diabetic rats. Ostomy/Wound Management. (animal study) — PubMed PMID: 28448268
- Robertson NU et al. (2020). Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews — PubMed PMID: 32990945
- Zhao H, Wu J, Wang N, Grether-Beck S, Krutmann J, Wei L (2021). Oral Pycnogenol® Intake Benefits the Skin in Urban Chinese Outdoor Workers: A Randomized, Placebo-Controlled, Double-Blind, and Crossover Intervention Study. Skin Pharmacology and Physiology — PubMed PMID: 33789311
- Cai C, Zeng B, Lin L, Zheng M, Burki C, Grether-Beck S, Krutmann J (2023). An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo-controlled, double blind intervention study. Health Science Reports — PubMed PMID: 36620515
PubMed Topic Searches
External Resources
Connections
- French Maritime Pine Bark Benefits Hub
- French Maritime Pine Bark for Circulation & Veins
- French Maritime Pine Bark: Standardization & Safety
- French Maritime Pine Bark (Main Page)
- Melasma
- Eczema
- Dermatology
- Vitamin C (collagen & skin)
- Astaxanthin (skin antioxidant)
- Grape Seed Extract (related OPCs)
- Resveratrol
- All Antioxidants